Burdensome device regulations take hold in Thailand
This article was originally published in Clinica
Medical device market growth in Thailand will be between 14% and 20% annually over the next several years, HIMA estimates. The market increased 19% in 1995 to reach $339 million, $54 million of which was contributed by imports from the US, up only 3% on the previous year. US manufacturers hold the largest share of the Thai market at 30%, with local producers accounting for another 22%.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.